Tata India Pharma & Healthcare Fund Direct Payout of Inc Dist cum Cap Wdrl
Sector - Healthcare
Equity
-
Last updated on 2022-12-30
3Y returns
+23.42%
| ₹18.56 Latest NAV | ₹-0.03 (-0.16%) 1D Change | ₹535.09 AUM |
|---|---|---|
| Very High Risk Risk Profile | ₹150 Min SIP | ₹5000 Min Leumpsum |
| None Lock-in period | 0.99% Expense Ratio | 0.3% before 30 Days Exit Load |
Price Chart
-5.91 1Y return
Chart is not available for selected time period
Top Holdings
Sun Pharmaceuticals Industries Ltd
18.61%
Cipla Ltd
12.89%
Dr Reddy's Laboratories Ltd
7.23%
Alkem Laboratories Ltd
6.02%
Apollo Hospitals Enterprise Ltd
5.90%
View All
Sector Breakdown
Healthcare
95.92%
Fund Manager
Meeta Shetty
Investment Objective
The investment objective of the scheme is to seek long term capital appreciation by investing atleast 80% of its net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.However, there is no assurance or guarantee that the investment objective of the Scheme will be achieved.The Scheme does not assure or guarantee any returns.
Download Scheme Document